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Retrograde axonal transport of nerve growth factor (NGF) signals
is critical for the survival, differentiation, and maintenance of
peripheral sympathetic and sensory neurons and basal forebrain
cholinergic neurons. However, the mechanisms by which the NGF
signal is propagated from the axon terminal to the cell body are yet
to be fully elucidated. To gain insight into the mechanisms, we
used quantumdot-labeled NGF (QD-NGF) to track themovement of
NGF in real time in compartmentalized culture of rat dorsal root
ganglion (DRG) neurons. Our studies showed that active transport
of NGF within the axons was characterized by rapid, unidirectional
movements interrupted by frequent pauses. Almost all movements
were retrograde, but short-distance anterogrademovementswere
occasionally observed. Surprisingly, quantitative analysis at the
single molecule level demonstrated that the majority of NGF-
containing endosomes contained only a single NGF dimer. Electron
microscopic analysis of axonal vesicles carrying QD-NGF confirmed
this finding. The majority of QD-NGF was found to localize in
vesicles 50–150 nm in diameter with a single lumen and no visible
intralumenal membranous components. Our findings point to the
possibility that a single NGF dimer is sufficient to sustain signaling
during retrograde axonal transport to the cell body.
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Nerve growth factor (NGF) is produced and released by targettissues to activate specific receptors at the axon terminals of
innervating neurons. In order for NGF to regulate gene expression
and the survival of target neurons, a signal must be moved a
considerable distance, in some cases 1,000-fold the diameter of
the neuron cell body. The elucidation of the mechanism(s) used to
transmit NGF signal from the terminals of axons to cell bodies of
neurons is yet to be fully defined. In that retrograde NGF signaling
is critical for the survival and maintenance of neurons of both the
peripheral and central nervous systems, and the underlying mech-
anisms are likely to be shared by related neurotrophic factors, the
issue remains one of the most significant and intriguing questions
in neurobiology (1–16).
In the past, radio-labeledNGF (125I-NGF) has been used to study
the binding, internalization, and axonal transport of NGF. These
studies facilitated the measurement of transport rate and provided
insights into the endocytic pathways used for NGF transport (8,
16–19). Fluorescent labels such as rhodamine (20), Texas red (21),
and Cy3 (22) were also used to track NGF movement in neurons.
However, because these previous methods have limited spatial and
temporal resolution, they provide only a coarse look at what is
expected to be a very dynamic process. Moreover, few studies have
examined NGF-containing endosomes during axonal transit. Some
have suggested that NGF is transported principally within early
endosomes (4, 5, 7–14) whereas others suggest that NGF is trans-
ported in organelles with complex membrane structures such as
multivesicular bodies (MVBs) (8, 20) and in macropinosomes (23).
Thus, how NGF is transported and in which organelle(s) are
unresolved questions.
In this study, we used quantum dots (QDs) to track retrograde
transport of NGF in compartmentalized cultures of rat dorsal root
ganglion (DRG) neurons. Using pseudoTIRF microscopy, we
tracked the movement of QD-NGF in live DRG neurons in real
time. Our approach uncovered previously unappreciated details of
the movement of NGF during retrograde transport. Endosomes
containing QD-NGF exhibited ‘‘stop-and-go,’’ unidirectional ret-
rograde motion with an average speed of 1.31  0.03 m/s.
Whereas our speed measurements are consistent with previous
bulk studies ofNGF transport (14), the ability to visualize individual
endosomes revealed a great diversity of transport phenomena.
Furthermore, wewere able to define the number ofNGFmolecules
contained in individual endosomes. Together with electron micros-
copy analysis, we found that the vast majority of endosomes
contained a single NGF dimer at physiological concentrations, and
that small vesicles (50–150 nm in diameter) contained 95% of
NGF.
Results
QD-NGF Is Fully Biologically Active. QDs are revolutionary fluores-
cent probes with excellent photostability (24).When combinedwith
ultrasensitive optical techniques, QDs allow tracking of individual
biomolecules in live cells with high signal-to-noise ratio and over
unprecedented durations (25–27). We examined retrograde trans-
port of NGF-containing vesicles by using QD-NGF to mark these
organelles. Purified NGF (28) was biotinylated (BtNGF) according
to published protocols (29, 30). On average, each dimer of BtNGF
contains 3 biotin additions. BtNGF was conjugated to QD-
streptavidin bymixing on ice overnight with amolar ratio of BtNGF
dimer to QD of 1 to 1.2. As assayed by SDS/PAGE gel, 6% of
BtNGFwas not coupled with QD [supporting information (SI) Fig.
6]. Unless explicitly noted otherwise, we used QDs with a fluores-
cence emission at 605 nm.
We used PC12 cells to determine whether or not the QD-NGF
complex retained the ability to bind specifically to NGF’s receptors.
PC12 cells, which endogenously express NGF receptors TrkA and
P75 (31), were incubated with QD-NGF (0.4 nM) at 37°C for 3 h.
Fluorescence imaging of such cells showed many bright puncta,
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indicating the presence of QD-NGF (Fig. 1ALeft). In a companion
study, using a mixture of native NGF and QDs (i.e., NGF that was
not complexedwithQD), we detected very little fluorescence signal
(Fig. 1A Right). We also detected robust binding of QD-NGF to
COS7 cells that were transfected with TrkA-GFP fusion protein,
whereas very little QD-NGF binding was present in COS7 cells that
were not transfected (SI Fig. 7). Thus, the presence of NGF was
necessary for binding of QD-NGF complexes to NGF receptors.
To determine whether the QD-NGF complex was capable of
activating NGF signaling pathways, we compared the responses
of PC12 cells to NGF, BtNGF and QD-NGF. Similar to the effect
of adding NGF or BtNGF alone, QD-NGF showed robust activa-
tion of TrkA, as well as Erk1/2 and Akt, two downstream signaling
proteins that play critical roles in NGF signaling pathways (Fig. 1B).
Consistentwith a recent report (32),QD-NGFwas able to stimulate
neurite outgrowth in PC12 cells (Fig. 1C). Judged by the dose–
response results for neurite outgrowth, the activity of QD-NGFwas
comparable with that of BtNGF as well as native NGF (Fig. 1D).
On the basis of these data, we conclude thatQD-NGF is biologically
active and induces physiologically significant responses.
QD-NGF Is Internalized at the Axon Terminal and Retrogradely Trans-
ported to the Cell Body. To show that the QD-NGF complex can be
internalized at axon terminals and retrogradely transported to
neuron cell bodies, we used CAMP10 Campenot chambers (33) to
culture embryonic dorsal root ganglion (DRG) neurons (Fig. 1E).
The three separate compartments, depicted in Fig. 1E, contain (i)
cell bodies and their most proximal axons (CB/PA); (ii) proximal
axons alone (PA); (iii) distal axons (DA) alone. QD-NGF (4 nM)
was applied exclusively to the DA compartment. For QD-NGF to
gain access to cell bodies, it must be internalized in distal axons and
retrogradely transported within axons. A five hour incubation
period was chosen to ensure that a sufficient number of QD-NGF
complexes were transported to the CB/PA chamber. At the con-
clusion of the incubation, all compartments were washed and cells
were fixed for fluorescence imaging. Fig. 1F shows that QD-NGF
was bound to most if not all axons in the DA compartment, as
evidenced by a prominent QD fluorescence signal over individual
axons and clusters of axons. In the CB/PA compartment, QD-NGF
was observed only in some proximal axons and cell bodies. We
estimated that 25% of cell bodies and 10% of proximal axons
were labeled. This labeling efficiency probably reflected the fact
that not all cell bodies extended axons into the distal chamber and
is further evidence that there was no leakage between CB/PA and
DA compartments.
As a control, we applied a mixture of native NGF and QDs, the
same final concentrations as above, to distal axons.We found5%
of the QD signals in the CB/PA compartment as compared with
QD-NGF complexes. In addition, we noted that retrograde trans-
port of QD-NGF was almost completely eliminated (1% of
normal transport) when axons in the DA compartment were
pretreated with 200 nM K252a, a known inhibitor of Trk tyrosine
kinase. This finding is consistent with previous studies (10, 34) that
Trk activation is required for NGF internalization. Given their
biological activity and marked stability, the QD-NGF complex
provides a useful tool for examining the axonal transport of NGF.
QD-NGF Containing Endosomes Exhibit Stop-and-Go Motion. For
imaging in live neurons, we combined a pseudoTIRF microscope
with a temperature-controlled stage constructed to hold the com-
partmented culture in the CAMP10 chamber. PseudoTIRF (see
Materials and Methods) is characterized by a low fluorescence
background, but allows for visualization of structures located up to
a few micrometers in from a glass-water interface; beyond the
illumination range of conventional TIRF microscopy. Our mea-
surements were performed at 34°C. QD-NGF (final concentration
1 nM) was applied exclusively to the DA compartment. It took
40min for the first few QD-NGF-containing endosomes to reach
the CB compartment, which is comparable with the 30- to 60-min
interval needed for transport of 125I-labeled NGF (16). We con-
fined fluorescence imaging of QDs exclusively to the CB/PA
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Fig. 1. Characterization of QD-NGF biological activity. (A) PC12 cells treated
with 0.4 nM of QD-NGF complex for 3 h at 37°C showed bright punctuate
fluorescence signal even after acid wash (Left). PC12 cells treated with the same
concentration of QD and native NGF mixture showed fewer if any fluorescent
puncta (Right). (B) Western blot analysis of phosphorylated TrkA (p-TrkA), phos-
phorylated Erk1/2 (p-Erk), and phosphorylatedAkt (p-Akt) protein levels in PC12
cells in response to the treatment of native NGF, BtNGF, and QD-NGF. The
phosphorylationofTrkApeakedat5minanddecreased slightly at 30min. Erk1/2
and Akt showed similar level of phosphorylation at 5 min and 30 min. The blots
were also probedwith antibodies sensitive to total Erk1/2 and total Akt to show
equal loading of cell lysate proteins. Application of native NGF, BtNGF and
QD-NGF at the same final concentration (2 nM) seemed to activate TrkA, Erk1/2,
and Akt to a similar extent. (C) Illustration of QD-NGF bioactivity in PC12-cells.
Two days treatmentwith 0.8 nMQD-NGF stimulated neurite outgrowth in PC12
cells. (D) Quantitative dose–response of PC12 cells to NGF, BtNGF and QD-NGF.
The percentage of cells bearing neurites was counted after 2 days of continuous
exposure to various concentrations of NGF, BtNGF and QD-NGF. (E) Schematic
drawing of a QD-NGF bound to dimerized TrkA receptors (Left) and addition of
QD-NGF to the DA compartment of the three-chamber DRG neuron culture
(CAMP10, Right). DA, distal axon; PA, proximal axon; CB, cell body. (F) (Upper)
Representative live fluorescence images of DRG neuron axons or cell bodies 2 h
after the addition of 4 nM QD-NGF to the DA chamber. (Lower) Images are the
results of these fluorescence images superimposed with their corresponding
bright-field images. QD-NGF seems to bind all axons in distal axon chamber.
However, only a small portionof the cell bodies andproximal axons are shownto
have QD fluorescence, reflecting the fact that not all cell bodies extend their
axons into the distal axon compartment.
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chamber to ensure that all of the QD-NGF complexes observed
were internalized and transported from the DA chamber.
Live-imaging revealed that endosomes containing QD-NGF
moved in a stop-and-go manner (see live imaging SI Movies 1–5).
A typical axon, containing four QD-NGF endosomes is shown in
Fig. 2A. The time-lapse trajectory shown in Fig. 2B, featuring
frequent switching frommoving to pausing and then tomoving, was
typical. In the vast majority of cases (90%), QD-NGF endosomes
moved exclusively toward the cell body. Even when anterograde
movement was observed, it generally persisted for a very short time
(0.5 s) and resulted in only small displacements.
Themoving speed and the duration of pauses varied greatly from
one endosome to another (Fig. 2C). At a QD-NGF concentration
of 1 nM, the average speed, which included both periods of active
movement and pausing, measured 1.31  0.03 m/s (mean and
uncertainty of themean). Pausing accounted for30%of time; the
speed during active movement was 2.11  0.05 m/s. Among
different endosomes, the average speeds varied from 0.2 m/s to 3
m/s and the moving speeds varied from 0.5 m/s to 5 m/s. Fig.
2D shows the distribution of average speeds. The variation in the
speeds could result from differences in the resistance to movement
within axons, in the motors used, or in the number of motors
engaged.
Endosomes in an Axon Move at a Similar Speed. Fig. 2E shows the
movement of 39QD-NGF containing endosomes in three different
axons. Endosomesmoving in the same axon are plotted in the same
color. All endosomes showed typical stop-and-go motion. The
green traces showed that endosomes in this axon moved with an
average speed of 2.29 0.39m/s. The endosomes shown in the red
traces paused longer and more frequently, resulting in an average
speed of 0.93 0.35 m/s, less than half of that for the axon whose
traces are shown in green. Thus, the average speed of endosomal
movement seems to vary considerably between axons, suggesting
differences in the ability of individual axons to support endosomal
traffic.
Some Endosomes in the Same Axon Pause at the Same Apparent
Axonal Location. In many axons, several QD-NGF-containing en-
dosomes were present and moving. They often exhibited a pattern
of movement that resembled multilane highway traffic. Most en-
dosomes moved independently of one another: fast moving ones
passed those moving more slowly or that were paused. Fig. 3A
shows a number of endosomes moving in the same axon. Each of
the two rapidly moving endosomes (no. 2 and no. 5) was observed
to pass the ones initially in front of them. We also noted examples
in which paused endosomes seemed to obstruct the advance of
other endosomes. Occasionally, two or more endosomes located
very near one another traveled at the same speed for a few seconds
before eventually separating. Fig. 3B plots the displacements vs.
time for 15 endosomes moving in a portion of one axon during a
period of 2 min. Red and green lines denote instances in which
endosomes passed each other. Interestingly, some, but not all,
endosomes that traveled in the same axon seemed to pause at the
same apparent location (as shown by the blue arrows in Fig. 3B).
This unexpected finding raises the possibility that pausing may be
influenced by local structural features in axons.
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Fig. 2. Live imaging reveals that endosomes containing QD-NGF exhibit
stop-and-go motion (see real-time SI Movies 1–5). (A) A typical axon showing
four moving endosomes that contained QD-NGF in pseudocolor. The back-
groundfluorescenceoutlines theaxon in this picture. (B) Trajectoryof a typical
endosome, showing a switch betweenmoving andpausing. (C) Trajectories of
120 endosomes showing that the moving speed and the duration of pauses
vary greatly from one endosome to another. (D) The average speed of endo-
somes containing QD-NGF varied from 0.2 to 3 m/s. (E) Comparison of
endosomes moving in three different axons. The trajectories of endosomes
within the same axon are denoted with the same color (red, blue or green).
The variability between different axons is significantly larger than the spread
of velocities in the same group.
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Fig. 3. Transport dynamics and concentration dependence of QD-NGF
containing endosomes. (A) Time-lapse video images (after background sub-
traction) of endosomes traveling on the same axon. Five endosomes were
visible at the beginning of the video recording, and the sixth endosome came
into the field of view after 6 s. The endosomes are numbered according to
their axonal positions at the start of the video recording. After 4 s, two fast
moving endosomes (no. 2 and no. 5) passed the slower ones (no. 1 and no. 4).
The white arrow indicates that direction of motion was toward the cell body.
(B) Trajectories of fifteen endosomes moving in the same axon through the
same field of view. The majority of endosomes move independently (black
circles). Endosomes moving together or passing another endosomes are
shown in red and green for clarity. The blue arrows indicate the places where
some trajectories paused at the same axonal location. (C) The number of
endosomes in a fixed length of axon increases with QD-NGF concentration.
Typical images showing the density of endosomes increases with QD-NGF
concentration (see real-time SI Movies 1–5). At 20 nM concentration, the
fluorescence intensity of individual endosomes contained QD-NGF increased
significantly. (D) Average number of endosomes per 1 mm of axons increases
with increased QD-NGF concentration ranging from 0.2 to 20 nM.
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The Number of QD-NGF-Containing Endosomes Increases with QD-NGF
Concentration. The number of QD-NGF-containing endosomes
observed in a fixed length of axon increased significantly with
increasing QD-NGF concentration in the range of 0.2 to 20 nM
(Fig. 3C). We detected no significant change in the stop-and-go
pattern of movement, or the average speed of movement, of
endosomes at different QD-NGF concentrations. QD-NGF con-
taining endosomes were readily detected at 0.2 nM, a concentration
that induced a robust neurite outgrowth response in PC12 cells (Fig.
1D). The distance between adjacent QD-NGF endosomes under
this condition averaged 69 m. With increasing QD-NGF con-
centration, the number of endosomes traveling in the axon in-
creased (Fig. 3 C and D). The number of endosomes per 1 mm of
axonwas estimated to be14 atQD-NGF concentration of 0.2 nM,
49 at 1 nM, and 83 at 2 nM and 252 at 20 nM. These
observations indicate that axonal transport of NGF is not saturated
even at concentrations that are beyond what is considered the
physiological range.
The Majority of Endosomes Contain a Single QD-NGF. The photo-
blinking property of QD fluorescence (35) (i.e., on-off-on fluores-
cence emission) allowed us to determine the number of QD-NGF
molecules per endosome. Under our experimental conditions, the
QD spends 5–10% of time in a dark state that does not emit
fluorescent light. Fig. 4A shows time-lapse images of an endosome
containing QD-NGF; the fluorescence intensity for this QD was
plotted in Fig. 4B. The sudden and complete lost of fluorescence in
the middle 7 frames denotes the blinking of a single QD (Fig. 4 A
and B). Endosomes containing a single QD were identified indi-
vidually by checking for blinking events for more than five consec-
utive frames (0.5 s). For endosomes that did not blink, the number
of QD-NGF complexes contained could be determined by com-
paring the fluorescence intensity to that for endosomes containing
a single QD-NGF that did blink. Because of the variation in the
fluorescence intensity of a singleQD, this numbermust be regarded
as an approximation. Using these measures, the majority (80%)
of endosomes in cultures treated with NGF at 1 nM, a concentra-
tion at which the neurite outgrowth response was maximal, con-
tained a single QD (Fig. 4C Top), of which 90% exhibited charac-
teristic photo-blinking. It should be noted that axons were not
always parallel to the glass surface so that QD-containing endo-
somes were seen to come in and out of the plane of focus as they
traveled along the axon; this out-of-focus movement caused fluo-
rescence intensity to fluctuate and sometimes lead to the complete
disappearance of QD fluorescence. However, these events were
easily distinguished from blinking by the much slower variation of
fluorescence intensity.
To confirm that most endosomes contained a single QD-NGF
complex, we mixed QD605-NGF (emission 605 nm) with QD705-
NGF (emission 705 nm) at a 1:1 ratio and applied the mixture to
theDA chamber of the compartmented culture. If most endosomes
contain two or more QD-NGF complexes, we would expect to see
a large fraction of them containing both QD605 and QD705. A
650-nm dichroic mirror spectrally resolved fluorescence emission
from QD605 or QD705. The fluorescence emission was further
filtered by passing through appropriate QD emission filters. En-
dosomes containing QD605 and those containing QD705 were
observed in the CB/PA compartment.Whereas a few of endosomes
were observed that contained both QD605 and QD705, the vast
majority (90%) contained either QD605 or QD705 (data not
shown). This result further strengthens the conclusion that majority
of endosomes contained a single QD-NGF.
To further confirm that a single QD-NGF complex transported
in an axon needs only a single NGF dimer (each QD contains
several streptavidin binding sties, as indicated in Fig. 1E.), we
prepared a QD-NGF mixture using a 10:1 molar ratio of QD to
BtNGF. Under this coupling condition, 5% of QD-NGF com-
plexes would be expected to contain more than one NGF dimer.
Endosomes containing a single QD-NGF complex were readily
detected. Statistical analysis revealed that 85% of endosomes
contained a single QD at this stoichiometry of QD toNGF (Fig. 4C
Bottom). Our finding strongly suggests that a single NGF dimer
resides within most retrogradely transported endosomes. In light of
earlier studies pointing to the ability to regenerate NGF signaling
during endosomal transport (10), it is possible that a single NGF
dimer can sustain signaling from endosomes during transport.
We investigated further how concentration influenced the num-
ber of QD-NGF complexes contained within endosomes. Fig. 4D
displays the distribution of the number of QD-NGF complexes
present in individual endosomes at each of several concentrations.
At concentrations of 0.2 and 1.0 nM, the majority of endosomes
contained a single QD-NGF complex (Fig. 4D Left and Center). At
20 nM, individual puncta showed notably enhanced fluorescence
intensity (Fig. 3C). Whereas it was difficult to define precisely the
number of QD-NGF complexes/endosome at 20 nM, we estimate
that 30% still contained just one (Fig. 4D Right).
Most QD-NGF Is Transported in Axons in Small 50- to 150-nm Vesicles.
One set of hypotheses for retrograde axonal transport ofNGF states
that NGF and its signaling proteins are transported in complex
vesicles such as multivesicular bodies, lysosomes, or macropino-
somes (8, 20, 36). To examine the endocytic compartment(s) that
immediate the retrograde transport of QD-NGF, we took advan-
tage of the fact that QD has an electron dense core that can be
visualized under electron microscopy (EM) (37). DRG neurons
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Fig. 4. Quantification of the number of QD-NGFs contained in individual
endosomes. (A) ‘‘Photo-blinking’’ of a single QD particle. A time sequenced
(every 0.1 s) images of a QD-NGF containing moving endosome. The sudden
disappearance of QDfluorescence for 0.7 s in themiddle is due to the intrinsic
photo-blinking property of QDs. Time trace of the fluorescence intensity of
the endosome is shown in B. The fluorescence intensity of the endosome is
consistent with the intensity of a single QD particle. The sudden decrease of
the fluorescence signal to background levels (‘‘blinking’’) is the signature of a
single QD particle. (C) Distribution of the number of QD particles contained in
endosomes when QDwas mixed with BtNGF at molar ratios of 1.2:1 and 10:1.
The number of QD particles in each endosome was quantified by measuring
both theblinkingevents and thefluorescence intensity. (D) Distributionof the
number of QD particles in endosome at the QD-NGF concentration of 0.2, 2
and 20 nM. The majority of endosomes contained a single QD-NGF at 0.2 and
2 nM. At 20 nM,30%of endosomes contained just oneQD-NGF and the rest
contained two or more QD-NGF conjugates.
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were cultured in the microfluidic chamber and treated with 2 nM
QD-NGF, as described above. Samples were rinsed and fixed for
EM analysis by using established protocols (37). A grid with pure
QD-NGFwas also imaged and used as a size guidance to determine
whether the black dots inside the vesicles were QDs. As shown in
Fig. 5A, a typical DRG axon has a diameter of 1 m. QDs were
often seen as 5 nm dark dots (arrow in Fig. 5A). QDs were most
easily seen in vesicles of 50–150 nm in diameter (mean  59  35
nm; n 84), that were uncoated and whose lumen was clear. As a
control, these distinctive electron-dense dotswere absent in samples
that were treated with NGF only. In agreement with the results of
live imaging studies (Fig. 4D), cells treated with 2 nM QD-NGF
showed that most QD-NGF containing vesicles contained 1 or 2
QDs (Fig. 5B). This result was independently verified at theMarine
Biological Laboratory (SI Fig. 8). We conclude that under the
condition of our experiments, small vesicles (50–150 nm) are
responsible for most retrograde axonal transport of QD-NGF in
DRG axons.
QD-NGF Colocalizes with Trk, pErk1/2, and Rab5B in Proximal Axons.
To show that QD-NGF containing endosomes carry the NGF
signal, we examined the distribution of these endosomes with
respect to that of signaling proteins that were shown to mediate
NGF signaling and associate with retrogradely transported endo-
somes under physiological conditions (11, 38). For this study, we
adopted amodified version ofmicrofluidic nerve cell chamber (39),
which enhances the ability to image and track QD signals (Fig. 5C).
MicrofluidicDRG cultures were deprived of NGF and serum for
24 h before QD-NGF was added to the distal axon compartment.
After 2 h of incubation, cells were extensively rinsed, fixed and
stained with antibodies to Trk, pErk1/2 (i.e., activated Erk1/2) by
using established protocols (11). Rab5, a marker of early endo-
somes, was also examined. The primary antibodies were detected
with Alexa 488-secondary antibody conjugates (green). Axons in
microgrooves were examined by using confocal microscopy. As
shown in Fig. 5D, QD-NGF (red) was essentially completely
colocalized with both Trk (top image inUpper) and Rab5B (middle
image inUpper). However, not all Trk, Rab5B signals were marked
byQD-NGF. This observationmay be explained, at least in part, by
the visualization of Trk and Rab5 not undergoing retrograde
transport. Among the 845 punta positive for Rab5B, 172 (20%)
were also positive for QD-NGF; among the 378 puncta positive for
Trk, 230 (61%) were also marked by QD-NGF. Like Trk and
Rab5, QD-NGF was colocalized with pErk1/2. Of the puncta
positive for pErk1/2, 77% (445/582) were also positive for QD-
NGF. Of note, some complexes were present in endosomes that
failed to stain positively for antibodies, or did so only weakly. These
results are evidence that QD-NGF is transported in early endo-
somes that also carry Trk and activated Erk1/2.
Discussion
The use of technologies such as (i) quantum dots labeled NGF, (ii)
microfluidic chambers for neuronal culture, (iii) pseudoTIRF mi-
croscopy, and (iv) single molecule detection and analysis, provided
us with the opportunity to study NGF retrograde transport in great
details. The ‘‘blinking’’ property and electron-dense core of QDs
led to the surprising discovery that most endosomes carried a single
NGF dimer at physiological concentrations. In view of recent
findings revealing impaired NGF transport in mouse models of
giant axonal neuropathy (40, 41) and Down syndrome (42), these
technologies may well facilitate studies of those systems in which
failed NGF transport contributes to neurodegeneration.
We are aware of the potential that QD labeling could alter
trafficking and signaling of NGF and have carefully considered this
issue in carrying out these studies and in interpreting our findings.
To this end, we have shown thatQD-NGFbinds specifically toNGF
receptors and activates NGF signaling pathways in a fashion similar
to unmodified NGF in PC12 cells. We have also demonstrated that
QD-NGF can be internalized at axon terminals and retrogradely
transported to neuron cell bodies. Also, the average moving speed
of QD-NGF within the axon (1.3 m/s) is in line with speeds
reported in the literature using 125I-NGF. We further used immu-
nofluorescence method to show that QD-NGF colocalized with
Rab5, TrkA, and pErk1/2. Taken together, these findings suggest
that QD labeling unlikely altered the signaling or trafficking of
NGF. Although conventional labeling methods have been used
with good effect to trace NGF transport, one can readily envision
that QDs will now be used routinely.
Materials and Methods
Production of Biotinylated NGF. Native NGF was purified from
mouse submaxillary glands following a published protocol (28).
NGF was biotinylated via carboxyl group substitution by using
EZ-link biotin-PEO-amine and the coupling reagent 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDAC) (Pierce Biotech,
Rockford, IL) as described by Bronfman et al. (29). The reaction
routinely yielded an average of three biotin molecules per NGF
dimer as assayed using FluoReporter Biotin Quantification kit
(Molecular Probes, Portland, OR). Streptavidin-quantum dots
(QD605, QD705), secondary antibodies conjugated to Alexa 488
were purchased from Invitrogen (Carlsbad, CA). Mouse IgGs
againstMcTrk, pErk1/2, rabbit IgGs againstRab5Bwere purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit IgGs
against phosphorylated Trk, phosphorylated Akt and total Akt
were from Cell Signaling Technology (Danvers, MA).
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Fig. 5. EM and immunostaining analysis of endosomes containing QD-NGF.
DRG neurons treated with QD-NGF were fixed, embedded and processed for
ultrathin sectioning. (A) A representative EM image of a cross-section of the
proximal axon portion showing that it contained many small vesicles (50–150
nm in diameter). One vesicle contained QD (arrows). (B) Out of 84 QD con-
taining vesicles, most had 1–2QD particles. (C) A representative image of DRG
neurons cultured inside a microfluidic device. Axons were able to extend
across two columns of microgrooves into the distal axon chamber. (D) After
QD-NGF was added to the DA chamber for 2 h, all chambers were rinsed and
fixed for immunostaining by using the indicated primary antibodies. A sec-
ondary antibody-Alexa 488 conjugate (green) was used to reveal these pri-
mary antibodies (green). We confined our observations to the sections of
axons leading to the cell body in themicrogrooves. The colocalization (yellow)
between QD-NGF (red) and Trk, Rab5B and pErk1/2 (all green) is extensive
(three panels in Upper). When QD was omitted, we were unable to detect a
red signal but the green signals for the other markers such as Trk (Lower)
remained.
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PC12 Cell Culture and Rat E16 DRG Culture. PC12 cells and were
maintained as described (38). Embryonic DRG neurons were
isolated fromSprague–Dawley fetal rats [embryonic day (E) 15 and
16], and cultured in DMEM containing 10% FCS and 50 ng/ml
NGF as described by Chan et al. (43). For compartmented culture,
a three-chamber Teflon divider (CAMP10, Tyler Research, Edm-
onton, Alberta, Canada) was sealed to a collagen-coated coverslip
with silicone grease.DissociatedDRGneuronswere plated into the
left most chamber. Axons crossed under the first grease barrier into
the central chamber within 5–7 days and reached the right chamber
(distal axon chamber) after crossing the second grease barrier in2
weeks. We also used modified microfluidic nerve cell chambers for
imaging and EM analysis (39). Unless indicated otherwise, 3- to
4-week-old cultures of DRG neurons were used in all experiments.
Immunofluorescence Staining and EM Analysis. After addition of
QD-NGF to the axons in the distal chamber, cultured DRG
neurons were fixed in 4% paraformaldehyde, permeabilized in
0.2% Triton X-100 in PBS, and blocked with 5% normal goat
serum for 1 h before the application of rabbit or mouse anti-
bodies against various proteins. The primary antibody was
visualized by using an appropriate secondary antibody-Alexa 488
conjugate. For EM analysis, a published protocol was followed
[Giepmans et al. (37)]. Electron micrographs were taken from
80-nm-thick sections at 120 kV with a transmission electron
microscope (Model: JEM-1200 EX II; Jeol Ltd.) at the EM
facility of Stanford University, and with a JEOL CX200 at the
Marine Biological Laboratory, Woods Hole, MA.
PseudoTIRF Microscope and Live Imaging. An inverted microscope
(Nikon TE2000U) wasmodified for pseudoTIRF illumination. The
laser beam (532 nm) was first expanded to 3 cm and then focused
at the back focal plane of the objective lens (Planapo60, 1.45 NA,
Olympus). The incident angle was adjusted to be slightly smaller
than the critical angle so that the laser beam could penetrate1m
into the aqueous solution.
To image transport of QD-NGF in live neurons, the compart-
mented culture was supplied with QD-NGF in the DA chamber for
3 h. The compartmented culture was mounted on a fabricated
microscope stage without removing the Teflon divider. Fluores-
cence images were filtered with a QD605/20 emission filter. Time-
lapse images were acquired by using an EMCCD camera (Cascade
512B; Roper Scientific) at the speed of 10 frames per second. For
dual imaging of QD605-NGF and QD705-NGF, the fluorescence
emission was split by a 650 nm dichroic mirror. The two spectrally
resolved copies of the microscope image were further filtered by
passing through QD605/20 or QD705/20 emission filters and re-
layed onto halves of the EMCCD camera. For further details, see
SI Materials and Methods.
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